BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 10904659)

  • 1. [Meningococcal disease in Africa--epidemiology and prevention].
    Norheim G; Rosenqvist E; Aavitsland P; Caugant DA
    Tidsskr Nor Laegeforen; 2000 Jun; 120(15):1735-9. PubMed ID: 10904659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal vaccine in travelers.
    Wilder-Smith A
    Curr Opin Infect Dis; 2007 Oct; 20(5):454-60. PubMed ID: 17762777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges for development of meningococcal vaccines in infants and children.
    Deasy A; Read RC
    Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2010 FIFA world cup South Africa: travel health issues and new options for protection against meningococcal disease.
    Zuckerman JN; Bröker M; Worth C
    Travel Med Infect Dis; 2010 Mar; 8(2):68-73. PubMed ID: 20478511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neisseria meningitidis and meningitis].
    Nicolas P; Debonne JM; Martet G
    Med Trop (Mars); 1999; 59(1):68-78. PubMed ID: 10472587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
    Xie O; Pollard AJ; Mueller JE; Norheim G
    Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project.
    Soriano-Gabarró M; Rosenstein N; LaForce FM
    J Health Popul Nutr; 2004 Sep; 22(3):275-85. PubMed ID: 15609780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
    Yogev R; Tan T
    Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines.
    Alderson MR; LaForce FM; Sobanjo-Ter Meulen A; Hwang A; Preziosi MP; Klugman KP
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S274-S278. PubMed ID: 31671447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global epidemiology of meningococcal disease.
    Harrison LH; Trotter CL; Ramsay ME
    Vaccine; 2009 Jun; 27 Suppl 2():B51-63. PubMed ID: 19477562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and meningococcal serogroup distribution in the United States.
    Hershey JH; Hitchcock W
    Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868
    [No Abstract]   [Full Text] [Related]  

  • 18. The epidemiology of meningococcal disease and the impact of vaccines.
    Khatami A; Pollard AJ
    Expert Rev Vaccines; 2010 Mar; 9(3):285-98. PubMed ID: 20218857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].
    Chippaux JP; Debois H; Saliou P
    Bull Soc Pathol Exot; 2002 Mar; 95(1):37-44. PubMed ID: 12012963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serogroup B meningococcal vaccines.
    Zimmer SM; Stephens DS
    Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.